ArticleDiagnostics (Basel, Switzerland)2023
Early Detection of Lung Nodules Using a Revolutionized Deep Learning Model.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Holistic Approach to Implementing Artificial Intelligence in Lung Cancer.Indian journal of surgical oncology · 2025Review
- Deciphering the Correlation between the Emergence of Lung Carcinoma Associated with Tuberculosis-related Inflammation.Endocrine, metabolic & immune disorders drug targets · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
According to the WHO (World Health Organization), lung cancer is the leading cause of cancer deaths globally. In the future, more than 2.2 million people will be diagnosed with lung cancer worldwide, making up 11.4% of every primary cause of cancer. Furthermore, lung cancer is expected to be the biggest driver of cancer-related mortality worldwide in 2020, with an estimated 1.8 million fatalities. Statistics on lung cancer rates are not uniform among geographic areas, demographic subgroups, or age groups. The chance of an effective treatment outcome and the likelihood of patient survival can be greatly improved with the early identification of lung cancer. Lung cancer identification in medical pictures like CT scans and MRIs is an area where deep learning (DL) algorithms have shown a lot of potential. This study uses the Hybridized Faster R-CNN (HFRCNN) to identify lung cancer at an early stage. Among the numerous uses for which faster R-CNN has been put to good use is identifying critical entities in medical imagery, such as MRIs and CT scans. Many research investigations in recent years have examined the use of various techniques to detect lung nodules (possible indicators of lung cancer) in scanned images, which may help in the early identification of lung cancer. One such model is HFRCNN, a two-stage, region-based entity detector. It begins by generating a collection of proposed regions, which are subsequently classified and refined with the aid of a convolutional neural network (CNN). A distinct dataset is used in the model's training process, producing valuable outcomes. More than a 97% detection accuracy was achieved with the suggested model, making it far more accurate than several previously announced methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.